Hoth Therapeutics Resumes At-the-Market Equity Offering Program

Hoth Therapeutics, Inc. has resumed its At-the-Market Equity Offering Program after previously suspending it. The company filed a new prospectus supplement to its Form S-3 registration statement, allowing it to raise capital through securities sales. This move aims to enhance financial flexibility for ongoing operations and development programs, potentially impacting its funding strategy and existing shareholders. Hoth Therapeutics focuses on developing therapeutic solutions and utilizes equity programs for financing.